-
Most Recent
Search Results
240 results for ANV
Why Did Annovis Bio (ANVS) Stock Close Up 80% Today?
ANVS stock closed up more than 75% today after Annovis announced encouraging clinical trial results for its Parkinson’s drug, buntanetap.
An AI Just Hacked a Company on Its Own
A Prisoner’s Dilemma with a Chinese accent… another Messy Middle story… OpenAI’s AI hacks Hugging Face… reader feedback about yesterday’s Digest
A New Reality for the AI Trade
Microsoft eases AI fears… the market’s new AI split… Luke Lango’s Exit Ladder if the selling returns… what the Fed’s preferred inflation gauge just revealed…
Most Startup Pitches Sound Great, so Here’s How to Find the Real Opportunities
Over years of studying some of history’s greatest venture capital successes, Luke Lango has developed a straightforward framework for evaluating young companies before they ever…
Annovis Bio (ANVS) Stock Soars 6% on Positive FDA Update
Annovis Bio (ANVS) stock is soaring higher on Thursday following a positive update from the FDA for its buntanetap clinical trial.
Apple’s Real AI Strategy Is Hiding in Its Acquisition History
Apple is searching for specialized AI technology. Q.ai shows why early investors may benefit before an acquisition is announced.
ANVS Stock Earnings: Annovis Bio Beats EPS for Q2 2024
ANVS stock results show that Annovis Bio beat analyst estimates for earnings per share the second quarter of 2024.
ANVS Stock Earnings: Annovis Bio Misses EPS for Q4 2023
ANVS stock results show that Annovis Bio missed analyst estimates for earnings per share the fourth quarter of 2023.
ANVS Stock Earnings: Annovis Bio Beats EPS for Q1 2024
ANVS stock results show that Annovis Bio beat analyst estimates for earnings per share the first quarter of 2024.
3 Gold Stocks That Are Breaking Out
Gold stocks are joining what looks to be the first major breakout in precious metals since August. These three stocks in particular look primed to…
Wall Street Left This Company for Dead. Then It Became the Trade of the Decade.
Five AI stocks look shaky on the surface, but the earnings tell a different story. See why the biggest gains in this boom may be…
5 Small-Cap Stocks to Buy
Here are five small-cap stocks that are likely to post spectacular earnings results this week.
10 Worst “Strong Sell” Stocks This Week — RDEN MDR ANV and more
This week, these ten stocks have the worst year-to-date performance. Each of these also rates an “F” (“strong sell”) on Portfolio Grader.
10 Worst “Strong Sell” Stocks This Week — ANV CLNE MDR and more
This week, these ten stocks have the worst year-to-date performance. Each of these also rates an “F” (“strong sell”) on Portfolio Grader.
5 Gold Stocks Set to Double in 2010
Gold is the best sector to invest in for 2010, and the five stocks I’m about to share with you are the best ways to…
How to Profit From the AI Boom Without Playing Big Tech’s Game
In today’s Smart Money, let’s look at the latest results from Alphabet Inc. (GOOGL) and Tesla Inc. (TSLA), and what they reveal about the Mag…
5 Gold Stocks and ETFs to Buy Now
More traders are looking to hide out in gold thanks to Thursday’s gut-wrenching ride. Here are five gold stocks and ETFs to cash in on…
10 Worst “Strong Sell” Stocks This Week — ANV CLNE MDR and more
This week, these ten stocks have the worst year-to-date performance. Each of these also rates an “F” (“strong sell”) on Portfolio Grader.
10 Worst “Strong Sell” Stocks This Week — ANV CDE MDR and more
This week, these ten stocks have the worst year-to-date performance. Each of these also rates an “F” (“strong sell”) on Portfolio Grader.
3 – 10 of 240 results
